文献速递认知障碍与痴呆脑血管病

大型医疗计划成员17年随访中高低密度脂蛋白胆固醇与痴呆风险的关系

Low- and High-Density Lipoprotein Cholesterol and Dementia Risk Over 17 Years of Follow-up Among Members of a Large Health Care Plan.
PubMed 文献 · Neurology · 2023-10-04

在Kaiser Permanente北加州医疗计划的184,367名55岁及以上成员中,随访至2020年12月,评估HDL-C和LDL-C与痴呆风险的关联。结果显示低和高HDL-C均与痴呆风险升高相关,LDL-C整体无关联但受他汀使用影响。

要点

  • HDL-C最低五分位与痴呆风险HR 1.07(95%CI 1.03-1.11),最高五分位HR 1.15(95%CI 1.11-1.20)。
  • LDL-C整体与痴呆风险无显著关联,但他汀使用者中每升高10 mg/dL的HR为1.01(95%CI 1.01-1.02)。
  • 非他汀使用者中LDL-C每升高10 mg/dL的HR为0.98(95%CI 0.97-0.99)。

核心结论

  • 低和高水平HDL-C均与痴呆风险升高相关,LDL-C与痴呆风险的关联较弱。

研究设计与样本

  • Kaiser Permanente北加州医疗计划的观察性队列研究,纳入184,367名55岁及以上成员,2002-2007年完成健康行为调查,随访至2020年12月。

主要发现

  • HDL-C最低五分位与痴呆风险HR 1.07(95%CI 1.03-1.11),最高五分位HR 1.15(95%CI 1.11-1.20),均以中间五分位为参照。
  • LDL-C整体与痴呆风险无显著关联,但他汀使用 qualitatively 修改了该关联。
  • 他汀使用者(占样本53%)中LDL-C每升高10 mg/dL的HR为1.01(95%CI 1.01-1.02),非使用者中HR为0.98(95%CI 0.97-0.99)。
  • 年龄与线性HDL-C存在效应修饰(p=0.003),与LDL-C无效应修饰(p=0.59)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The associations of high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) with dementia risk in later life may be complex, and few studies have sufficient data to model nonlinearities or adequately adjust for statin use. We evaluated the observational associations of HDL-C and LDL-C with incident dementia in a large and well-characterized cohort with linked survey and electronic health record (EHR) data. METHODS: Kaiser Permanente Northern California health plan members aged 55 years and older who completed a health behavior survey between 2002 and 2007, had no history of dementia before the survey, and had laboratory measurements of cholesterol within 2 years after survey completion were followed up through December 2020 for incident dementia (Alzheimer disease-related dementia [ADRD]; Alzheimer disease, vascular dementia, and/or nonspecific dementia) based on ICD-9 or ICD-10 codes in EHRs. We used Cox models for incident dementia with follow-up time beginning 2 years postsurvey (after cholesterol measurement) and censoring at end of membership, death, or end of study period. We evaluated nonlinearities using B-splines, adjusted for demographic, clinical, and survey confounders, and tested for effect modification by baseline age or prior statin use. RESULTS: A total of 184,367 participants [mean age at survey = 69.5 years, mean HDL-C = 53.7 mg/dL (SD = 15.0), mean LDL-C = 108 mg/dL (SD = 30.6)] were included. Higher and lower HDL-C values were associated with elevated ADRD risk compared with the middle quantile: HDL-C in the lowest quintile was associated with an HR of 1.07 (95% CI 1.03-1.11), and HDL-C in the highest quintile was associated with an HR of 1.15 (95% CI 1.11-1.20). LDL-C was not associated with dementia risk overall, but statin use qualitatively modified the association. Higher LDL-C was associated with a slightly greater risk of ADRD for statin users (53% of the sample, HR per 10 mg/dL increase = 1.01, 95% CI 1.01-1.02) and a lower risk for nonusers (HR per 10 mg/dL increase = 0.98; 95% CI 0.97-0.99). There was evidence for effect modification by age with linear HDL-C (p = 0.003) but not LDL-C (p = 0.59). DISCUSSION: Both low and high levels of HDL-C were associated with elevated dementia risk. The association between LDL-C and dementia risk was modest.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ferguson EL, Zimmerman SC, Jiang C, et al. Low- and High-Density Lipoprotein Cholesterol and Dementia Risk Over 17 Years of Follow-up Among Members of a Large Health Care Plan. Neurology. 2023. PMID: 37793911. doi:10.1212/WNL.0000000000207876

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。